NCT04489238 Collection of Information to Better Understand Young Onset Colorectal Cancer
| NCT ID | NCT04489238 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,366 participants |
| Start Date | 2020-07-22 |
| Primary Completion | 2026-07-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,366 participants in total. It began in 2020-07-22 with a primary completion date of 2026-07-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this registry study is to create a database-a collection of information-for better understanding young onset colorectal cancer. Colorectal cancer patients are considered to have young onset colorectal cancer if they are diagnosed with their cancer before the age of 50. Researchers will use the information from this database to learn more about how young onset colorectal cancer may be similar to or different from colorectal cancer that is diagnosed later in life. Researchers will also use information from the database for current and future research on young onset colorectal cancer.
Eligibility Criteria
Inclusion Criteria: Participant Inclusion Criteria for database and questionnaire (YOGI) * Histological or cytological diagnosis of gastrointestinal cancer * 18 - 49 years old at time of consent * No Known hereditary CRC or other cancer predisposition syndrome (stool collection cohort only) * No history of inflammatory bowel disease (stool collection cohort only) * No prior diagnosis of gastrointestinal cancer (stool collection cohort only) Participant Inclusion Criteria for database and questionnaire (Controls) * Histological or cytological diagnosis of colorectal adenocarcinoma * No previous treatment for CRC (including surgery, chemotherapy, immunotherapy or radiation) * Age 50 or older at time of consent * No Known hereditary CRC or other cancer predisposition syndrome * No history of inflammatory bowel disease * No prior diagnosis of CRC
Contact & Investigator
Andrea Cercek, MD
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT04489238 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04489238 currently recruiting?
Yes, NCT04489238 is actively recruiting participants. Contact the research team at cerceka@mskcc.org for enrollment information.
Where is the NCT04489238 trial being conducted?
This trial is being conducted at Basking Ridge, United States, Middletown, United States, Montvale, United States, Commack, United States and 4 additional locations.
Who is sponsoring the NCT04489238 clinical trial?
NCT04489238 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Andrea Cercek, MD at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 1,366 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.